All In Biotech

Drug Trial Radar · NCT00149188

Somatuline Autogel: Acromegaly Self/Partner Injection Study

A Phase IV, Multicentre, Open Label, Controlled Study to Assess the Ability of Patients With Acromegaly, or Their Partners, to Administer Somatuline Autogel.

Last checked: Nov 20, 2026Latest source record: Aug 5, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

30

Actual

Start

Feb 2004

Primary completion

Aug 24, 2005

Study completion Aug 24, 2005

Sponsor

Lead sponsor
IpsenIndustry
Sponsor type
Industry
First posted
Sep 8, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to allow patients with acromegaly, or their partners, to learn how to successfully inject Somatuline Autogel at home. Ability to perform unsupervised injections whilst maintaining adequate disease control will be assessed.

Conditions

  • Acromegaly

Interventions

  • Lanreotide (Autogel formulation)Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To assess the ability of patients or their partners to perform unsupervised Somatuline Autogel injections.

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Dept of Endocrinology, Aberdeen Royal Infirmary

    Aberdeen, United Kingdom

  • Department of Medicine, Queen Elizabeth Hospital

    Birmingham, United Kingdom

  • Department of Endocrinology, Coventry & Warwickshire Hospital

    Coventry, United Kingdom

  • Department of Endocrinology, Leicester Royal Infirmary

    Leicester, United Kingdom

  • Department of Endocrinology, Manchester Royal Infirmary

    Manchester, United Kingdom

  • The Oxford Centre for Diabetes, Endocrinology and Metabolism, The Churcill Hospital

    Oxford, United Kingdom

  • Department of Endocrinology, Royal Hallamshire Hospital

    Sheffield, United Kingdom

  • Department of Endocrinology, Sunderland Royal Hospital

    Sunderland, United Kingdom

  • Michael White Centre Diabetes & Endocrinology, Hull Royal Infirmary

    Hull, East Yorkshire, United Kingdom

  • Department of Endocrinology, The Royal Free Hospital

    Hampstead, London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.